Emily Razaqi is senior vice president, Obesity and Related Conditions. She is responsible for ensuring cross-functional alignment and timely execution of launch plans across Research and Development, Operations, Commercial, and other teams as appropriate. Additionally, Razaqi serves as chair of the Amgen Foundation, and is the executive sponsor of the Amgen Asian Association employee resource group.

Razaqi joined Amgen in 2004 and has held a variety of roles across the company and around the world. In her previous roles at Amgen, she served as senior vice president of Corporate Affairs, General Manager of Amgen's Biosimilars group and as vice president of Amgen Singapore Site Operations. Prior to that, Razaqi was a Global Product General Manager and Global Operations Leader in Amgen’s cardiovascular therapeutic area. She started her career in management consulting at the Boston Consulting Group.

Razaqi earned her bachelor’s degree in Industrial Engineering and a master’s degree in Industrial Engineering & Engineering Management from Stanford University.